Efficacy observation on compound Tufuling tablets in the treatment of chronic prostatitis due to damp heat stagnation
10.3760/cma.j.issn.1673-4246.2015.04.007
- VernacularTitle:复方土茯苓片治疗湿热瘀滞型慢性前列腺炎的疗效评价
- Author:
Jianwu SHEN
;
Qi LI
;
Kuiqing SHAO
;
Shuangxi LYU
;
Zhan GAO
;
Ding LI
;
Fanxiong ZENG
- Publication Type:Journal Article
- Keywords:
Prostatitis;
Compound Tufuling tablets;
Treatment outcome
- From:
International Journal of Traditional Chinese Medicine
2015;(4):311-314
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical curative effect of compoundTufuling tablets in the treatment of chronic prostatitis due to damp heat stagnation.Methods A total of 60 patients with chronic prostatitis due to damp heat stagnation were selected from July 2012 to July 2013 in Urology Outpatient of Urology, Xiyuan Hospital and recruited randomly divided into 2 groups, 30 patients in each group. The treatment group was treated with compound SmilaxTufuling tablets, while the control group was treated with Qianliexin capsule. The National Institutes of Health Chronic Prostatitis Symptom Index (NHI-CPSI), and the TCM symptoms score for chronic prostatitis were used to evaluate the treatment outcome.Results The total efficiency in the treatment group was significant higher than that in the control group (89.3%vs. 64.3%;χ2=4.909,P=0.027). After treatment , the NIH-CPSI total score (6.00 ± 2.36vs. 13.61 ± 2.91;t=10.748, P=0.000), and the subscales of pain or discomfort (2.54 ± 1.14vs. 4.82 ± 1.47;t=6.486,P=0.000), urination (1.61 ± 1.45vs. 4.79 ± 2.75;t=5.413,P=0.000), the quality of life (1.86 ± 1.38vs. 7.00 ± 1.36;t=14.038, P=0.000), TCM symptoms score (8.36 ± 3.03vs. 5.32 ± 2.74;t= 9.015,P=0.000) in the treatment group were decreased than those in the control group.Conclusions CompoundTufuling tablets can significantly decrease the NIH-CPSI scale and the TCM symptoms score in patients with chronic prostatitis due to damp heat stagnation, boosting satisfactory clinical effects.
